Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
U.S. to Ban Some Investments in China
President Biden plans to sign an executive order that will also require U.S. private-equity and venture-capital firms to disclose certain investments in the country. Source
Paramount to Sell Simon & Schuster to KKR for $1.62 Billion
The sale of the book publisher to the buyout firm comes less than a year after previous deal with Penguin Random House was blocked. Source
Kim Kardashian Taps Ex-Apple, Burberry Executive for Private-Equity Firm
Angela Ahrendts will be joining SKKY Partners as senior operating adviser. Source link
Efforts to Spotlight Private Equity's Healthcare Stakes Struggle for Traction
Congress and regulatory agencies have made scant headway in requiring medical companies to reveal owners. Source link
Pratt & Whitney Engine Problems Lead Airlines to Reduce Some Flights
The aerospace and defense company RTX’s bet on single-aisle jetliners has run into quality and durability concerns. Source link
Superconductors' Viral 'LK-99' Moment Takes Investors for a Wild Ride
Share prices skyrocket, then sink, for companies that don’t even have a direct link to room-temperature superconductors. Source link
Private-Equity Firm KKR in Advanced Talks to Buy Simon & Schuster for Roughly $1.65 Billion
Book publisher was put up for sale for the second time after a judge blocked a previous deal with Penguin Random House. Source link
New Definition of 'Fraud' Wipes Out High-Profile Prosecutions
Fraud doesn’t mean what it used to—and several high-profile federal prosecutions are falling apart as courts apply the Supreme Court’s more-narrow legal definition. Source link
Private Equity, Hedge Funds Brace for Coming SEC Overhaul
Regulators could adopt new rules for firms such as Blackstone and Millennium as soon as this month. Source link
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that